Claritev Corporation
CTEVNYSEHealthcare● Active
$27.07
+$1.23(+4.76%)
Market Cap$461483648
P/E Ratio—
52W High$74.07
52W Low$11.5
Claritev Corporation (CTEV) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CTEV · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.28B) | ($1.65B) | ($0.09B) | ($0.57B) | $0.10B |
| Depreciation & Amort. | $0.45B | $0.44B | $0.43B | $0.42B | $0.42B |
| Stock-Based Comp. | $0.03B | $0.03B | $0.02B | $0.02B | $0.02B |
| Change in Working Capital | ($0.03B) | ($0.01B) | ($0.02B) | $0.06B | ($0.05B) |
| Net Cash from Operations | $0.12B | $0.11B | $0.17B | $0.37B | $0.40B |
| Investing Activities | |||||
| Capital Expenditure | ($0.13B) | ($0.12B) | ($0.11B) | ($0.09B) | ($0.08B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | ($0.01B) | $0.00B |
| Sales of Investments | $0.02B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.12B) | ($0.12B) | ($0.25B) | ($0.10B) | ($0.23B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | ($0.01B) | ($0.02B) | ($0.10B) | ($0.10B) |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | ($0.03B) | ($0.17B) | ($0.01B) | ($0.01B) |
| Net Cash from Financing | $0.00B | ($0.04B) | ($0.18B) | ($0.12B) | ($0.11B) |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.01B) | ($0.01B) | $0.06B | $0.28B | $0.32B |
| FCF Margin %(computed) | -1.27% | -1.13% | 6.54% | 26.18% | 28.64% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Claritev Corporation data
About Claritev Corporation (CTEV) Cash Flow Statement
Claritev Corporation generated operating cash flow of $0.12B and free cash flow of ($0.01B) for 2025 — a FCF margin of -1.27%. Capital expenditure was ($0.13B).
Frequently asked questions
CTEV · 4 questionsClaritev Corporation generated free cash flow of ($0.01B) for 2025, down 16.8% year-over-year.
CTEV free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10